Edwards Lifesciences Corp EW
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- CHF 205.88–205.88
- Bid/Ask
- CHF 71.68 / CHF 72.63
- Shares Outstanding
- 576.40M
- Market Cap
- $46.33B
- Volume/Avg
- 2,064 / —
Key Statistics
- Price/Earnings (Normalized)
- 31.99
- Price/Sales
- 8.02
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.30%
Company Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 16,000
- Website
- https://www.edwards.com
Valuation
|
Metric
|
EW
|
|---|---|
Price/Earnings (Normalized) | 31.99 |
Price/Book Value | 4.79 |
Price/Sales | 8.02 |
Price/Cash Flow | 31.81 |
Price/Earnings
EW
Financial Strength
|
Metric
|
EW
|
|---|---|
Quick Ratio | 3.45 |
Current Ratio | 4.52 |
Interest Coverage | — |
Quick Ratio
EW
Profitability
|
Metric
|
EW
|
|---|---|
Return on Assets (Normalized) | 12.05% |
Return on Equity (Normalized) | 15.67% |
Return on Invested Capital (Normalized) | 13.78% |
Return on Assets
EW
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|@@k$$!X | LOCK|^wVc | $173B | |||
| Medtronic PLC
MDT
| LOCK|s#DlG>Y | LOCK|z&DF | $113B | |||
| Stryker Corp
SYK
| LOCK|?Pf<x$$ | LOCK|P$ | $109B | |||
| Boston Scientific Corp
BSX
| LOCK|W%%!L$ | LOCK|c<^Wh | $61B | |||
| Edwards Lifesciences Corp
EW
| LOCK|TD$>V<f | LOCK|@#^nZ | $50B | |||
| DexCom Inc
DXCM
| LOCK|^$HlPW^# | LOCK|s$g<& | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|HV#@?< | LOCK|^VY | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|NNT | LOCK|RT | $23B | |||
| Steris PLC
STE
| LOCK|jyMT>gw | LOCK|y>HT$ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|&&hDnBB& | LOCK|yf^ | $17B |
United States